$ITCI Pullback to 50 MA LineNASDAQ:ITCI orderly pullback to its 50 line MA after a strong move up.
Volume pattern looking strong with U/D north of 1.5
less than 2.8% risk to know if uptrend is resuming with inside day making for low risk entry.
−1.63USD
−256.256MUSD
250.314MUSD
93.649M
About Intra-Cellular Therapies Inc.
Sector
CEO
Sharon L. Mates
Headquarters
New York
Website
Employees (FY)
561
Founded
2002
ISIN
US46116X1019
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. The firm’s lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. It also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in New York, NY.
ITCI potential breakout tradeITCI is a biotech setting up for a potential breakout at the $60 level. The biotech sector is showing market-leading strength off the lows with many stocks in this group at or making new highs.
Relative strength ranks 97/100 and the company has seen triple-digit sales growth in each of the last fou
Intra-Cellular Therapies Announces FDA Approval of New DosageITCI: Intra-Cellular Therapies Inc.
2022-04-25 07:00:00
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
ITCI New All Time Highs*ITCI Made a New All Time High Yesterday
*7 Year Long Base Breakout
*As it has a bigger base so need to observe on weekly chart
*Very strong momentum
*Can be a decent swing play from here
1/3/2022 NASDAQ (ITCI)Buy (Entry Price) within the buy zone area and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price.
ITCI - place your betsWith a huge upcoming catalyst - CAPLYTA PDUFA due December 17th, 2021, it will make or break this stock - with an approval from the FDA, I expect pt of around 57, with possibility to hit all-time high within a year from CAPLYTA launch. There is however always a possibility of CRL from the FDA, if th
WATCHING $ITCI for ENTRY TARGET @ 37.23WATCHING $ITCI for ENTRY TARGET @ 37.23
Practicing to nail my entries even tighter… if target hits I will take a position.
Just because I'm watching doesn't mean I will actually take a position. I guess it just depends on what my portfolio is doing at the moment.
Intra-Cellular Therapies... That
ITCI - Rising wedgeAbout to break through resistance, looking tight
**Warning: Earnings date approaching on 2/25**
Cup and HandleEstmated Earnings 2-26..
No rising wedges in the yearly chart..
Short interest a bit over 10%..
There is also an inverse H&S pattern but target would put you at top of cup..
Mid Cup is 28.33. Support is often found under mid cup or handle low (HL)
Not a recommendation
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
